The office manager of Memorial Home Health in New Orleans has been sentenced this week for taking part in the company’s $50 million fraud scheme. 

The University of Chicago Medicine and Ingalls Health System agreed to pursue a combined integrated health delivery system. Once the deal is final, Ingalls Health System will join the University of Chicago Medicine health network. 

Thirty CEOs shared their daily habits with Inc. magazine and how their routines have made them successful. For instance, the executives suggested keeping track of industry news, being punctual, experimenting with new habits and processes and learning from other leaders.

Almost 10 percent of healthcare company board positions are held by top academics from many of the top-ranked U.S. medical and research institutions, revealing the potential for significant conflicts of interests. 

Nearly half of respondents to a recent survey said their organizations had a physician leadership development training program, while 95 percent said leadership competencies were important in the medical profession.

The American Heart Association (AHA) warned of a scam in which people are identifying themselves as AHA CEO Nancy Brown and/or AHA chief mission officer Meighan Girgus and contacting individuals for job interviews.

Consumers with unpaid medical bills will have a better chance to resolve disputes under new rules announced on March 9, the Wall Street Journal reports.

Hospital executives are optimistic the Supreme Court will rule in favor of the defendant in the King v. Burwell case and not make changes to the Patient Protection and Affordable Care Act, Reuters reports.

Nearly three-quarters of healthcare executives perform data analytics, Health Data Management reports.

People looking for inspiration or mentoring advice can follow tips from successful leaders, The Muse reports.

After six years on the job, FDA Commissioner Margaret Hamburg, MD, is stepping down, reports Clinical Innovation + Technology.

In a deal that will transform the pharmaceutical industry, Pfizer announced that it will buy rival Hospira for $16 billion, reports Wall Street Journal.